Sign In
Buy PCRX
Pacira Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -17.15. In total, the insiders bought 1.06B and sold 222.69K PCRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-17.15 |
| ● Buy | 1.06B shares |
| ● Sell | 222.69K shares |
|
68% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 11, 2026 Sell |
Riker Lauren Senior Vice President, Finance |
6 115 Value: $143.7K |
||
|
Jun 10, 2026 Buy |
Brege Laura Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Brege Laura Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Froimson Mark Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Froimson Mark Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Bigal Marcelo Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Wiggans Thomas G Director |
32 675 Value: $765.2K |
||
|
Jun 10, 2026 Buy |
Christie Christopher Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Christie Christopher Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Hirawat Samit Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Hirawat Samit Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Young Alethia Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Young Alethia Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Yang Michael J. Director |
6 405 Value: $150.0K |
||
|
Jun 10, 2026 Buy |
Yang Michael J. Director |
10 891 Value: $255.1K |
||
|
Jun 10, 2026 Buy |
Bigal Marcelo Director |
6 405 Value: $150.0K |
||
|
Jun 09, 2026 Buy |
Wiggans Thomas G |
0 Value: $0 |
||
|
Jun 04, 2026 Sell |
Williams Kristen Chief Administrative Officer |
10 259 Value: $228.5K |
||
|
Jun 03, 2026 Sell |
Riker Lauren Senior Vice President, Finance |
3 187 Value: $71.1K |
||
|
Jun 03, 2026 Sell |
Slonin Jonathan Chief Medical Officer |
4 728 Value: $105.5K |
||
|
Jun 03, 2026 Sell |
Williams Kristen Chief Administrative Officer |
8 528 Value: $190.3K |
||
|
Apr 23, 2026 Buy |
Cross Shawn Chief Financial Officer |
12 941 Value: $212.9K |
||
|
Apr 23, 2026 Buy |
Cross Shawn Chief Financial Officer |
12 941 Value: $212.9K |
||
|
Apr 23, 2026 Sell |
Cross Shawn Chief Financial Officer |
12 941 Value: $325.6K |
||
|
Apr 22, 2026 Sell |
Cross Shawn Chief Financial Officer |
1 500 Value: $37.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
